Bellerophon Therapeutics Stock Price, News & Analysis

BLPH OTC

Company Description

Bellerophon Therapeutics (OTC: BLPH) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

BLPH stock has declined 63.1% over the past year. Shares last traded at $0.0545.

This page provides a comprehensive overview of BLPH stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-63.08%

Performance 1 year

$0.0

Market Cap

12.2M

Shares outstanding

Bellerophon Therapeutics (BLPH) stock last traded at $0.0545. Over the past 12 months, the stock has lost 63.1%.

Latest News

View All

June 5, 2023

-86.64%

Bellerophon Announces Top-Line Data from Phase 3 REBUILD Clinical Trial of INOpulse® for Treatment of Fibrotic Interstitial Lung Disease

clinical trial

May 15, 2023

+19.29%

Bellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial Results

earnings

May 11, 2023

+2.43%

Bellerophon Therapeutics Announces Last Patient Has Completed Blinded Treatment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Disease

clinical trial

March 31, 2023

+5.76%

Bellerophon Provides Clinical Program Update and Reports Full-Year 2022 Financial Results

earnings

March 6, 2023

+94.10%

Bellerophon Therapeutics Announces $5 Million Registered Direct Offering

offering

February 9, 2023

-9.64%

Bellerophon Therapeutics Receives IND Clearance from China NMPA to Conduct Phase 3 Clinical Trial in China for INOpulse® in Fibrotic Interstitial Lung Disease

clinical trial

Bellerophon Therapeutics has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include clinical trial, earnings, offering, fda approval. View all BLPH news →

SEC Filings

View All

No SEC filings available for BLPH.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

BLPH Company Profile & Sector Positioning

Bellerophon Therapeutics (BLPH) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.

Frequently Asked Questions

What is the current stock price of Bellerophon Therapeutics (BLPH)?

The current stock price of Bellerophon Therapeutics (BLPH) is $0.0545 as of April 16, 2024.